Validation of keratan sulfate level in mucopolysaccharidosis type IVA by liquid chromatography-tandem mass spectrometry

Journal of Inherited Metabolic Disease

Volumn 33, Issue SUPPL. 3, 2010, Pages

  Tomatsu, Shunji ^a   Montaño, Adriana M ^a   Oguma, Toshihiro ^b   Dung, Vu Chi ^a   Oikawa, Hirotaka ^a   De Carvalho, Talita Giacomet ^a   Gutiérrez, María L ^a   Yamaguchi, Seiji ^c   Suzuki, Yasuyuki ^d   Fukushi, Masaru ^e   Kida, Kazuhiro ^f   Kubota, Mitsuru ^f   Barrera, Luis ^g   Orii, Tadao ^d  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DAIICHI SANKYO CO   (Japan)

^c SHIMANE UNIVERSITY   (Japan)

^d GIFU UNIVERSITY   (Japan)

^e Sapporo City University   (Japan)

^f HOKKAIDO UNIVERSITY   (Japan)

^g PONTIFICIA UNIVERSIDAD JAVERIANA   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; KERATAN SULFATE;

ADOLESCENT; ADULT; ARTICLE; BLOOD; CASE CONTROL STUDY; CHILD; EARLY DIAGNOSIS; HUMAN; INFANT; LIQUID CHROMATOGRAPHY; MIDDLE AGED; MORQUIO SYNDROME; PREDICTIVE VALUE; PRESCHOOL CHILD; REPRODUCIBILITY; SEVERITY OF ILLNESS INDEX; TANDEM MASS SPECTROMETRY; UPREGULATION; VALIDATION STUDY; YOUNG ADULT; MUCOPOLYSACCHARIDOSIS IV;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CHROMATOGRAPHY, LIQUID; EARLY DIAGNOSIS; HUMANS; INFANT; KERATAN SULFATE; MIDDLE AGED; MUCOPOLYSACCHARIDOSIS IV; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; TANDEM MASS SPECTROMETRY; UP-REGULATION; YOUNG ADULT;

EID: 84897927019     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-009-9013-x     Document Type: Article

References (24)

1. Beck M, Glossl J, Grubisic A, Spranger J (1986) Heterogeneity of Morquio disease. Clin Genet 29:325-331
2. Bjornsson S (1993) Simultaneous preparation and quantitation of proteoglycans by precipitation with alcian blue. Anal Biochem 210:282-291
3. Caterson B, Christner JE, Baker JR (1983) Identification of a monoclonal antibody that specifically recognizes corneal and skeletal keratan sulfate. Monoclonal antibodies to cartilage proteoglycan. J Biol Chem 258:8848-8854
4. Dorfman A, Arbogast B, Matalon R (1976) The enzymic defects in Morquio and Maroteaux-Lamy syndrome. Adv Exp Med Biol 68:261-276
5. Fang-Kircher SG, Herkner K, Windhager R, Lubec G (1997) The effects of acid glycosaminoglycans on neonatal calvarian cultures-A role of keratan sulfate in Morquio syndrome? Life Sci 61:771-775
6. Fujimoto A, Horwitz AL (1983) Biochemical defect of non-keratansulfate- excreting Morquio syndrome. Am J Med Genet 15:265-273
7. Glössl J, Kresse H (1982) Impaired degradation of keratan sulphate by Morquio A fibroblasts. Biochem J 203:335-338
8. Kinoshita A, Sugahara K (1999) Microanalysis of glycosaminoglycanderived oligosaccharides labeled with a fluorophore 2-Aminobenzamide by high-performance liquid chromatography: application to disaccharide composition analysis and exosequencing of oligosaccharides. Anal Biochem 269:367-378
9. Mehmet H, Scudder P, Tang PW, Hounsell EF, Caterson B, Feizi T (1986) The antigenic determinants recognized by three monoclonal antibodies to keratan sulphate involve sulphated hepta-or larger oligosaccharides of the poly (N-Acetyllactosamine) series. Eur J Biochem 157:385-391
10. Montaño AM, Tomatsu S, Gottesman GS, Smith M, Orii T (2007) International Morquio A registry: clinical manifestation and natural course of Morquio A disease. J Inherit Metab Dis 30:165-174
11. Montaño AM, Tomatsu S, Brusius A, Smith M, Orii T (2008) Growth charts for patients affected with Morquio A disease. Am J Med Genet A 15;146:1286-1295
12. Neufeld EF, Muenzer J (2001) The mucopolysaccharidoses. In: Scriver CR, Beaudet al., Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease, 8th edn. McGraw-Hill, New York, pp 3421-3452
13. Northover H, Cowie RA, Wraith JE (1996) Mucopolysaccharidosis type IVA (Morquio syndrome): a clinical review. J Inherit Metab Dis 19:357-365
14. Oguma T, Tomatsu S, Okazaki O (2007) Analytical method for determination of disaccharides derived from keratan sulfates in human serum and plasma by high-performance liquid chromatography/turbo-ionspray ionization tandem mass spectrometry. Biomed Chromatogr 21:356-362
15. Ohashi A, Montaño AM, Colón JE, Oguma T, Luisiri A, Tomatsu T (2009) Sacral dimple: Incidental findings from newborn evaluation. Acta Paediatr 98:768-769, 910-912
16. Thonar EJ, Lenz ME, Klintworth GK, Caterson B, Pachman LM, Glickman P, Katz R, Huff J, Kuettner KE (1985) Quantification of keratan sulfate in blood as a marker of cartilage catabolism. Arthritis Rheum 28:1367-1376
17. Thonar EJ, Pachman LM, Lenz ME, Hayford J, Lynch P, Kuettner KE (1988) Age related changes in the concentration of serum keratan sulphate in children. J Clin Chem Clin Biochem 2:57-63
18. Tomatsu S, Okamura K, Taketani T, Orii KO, Nishioka T, Gutierrez MA, Velez-Castrillon S, Fachel AA, Grubb JH, Cooper A, Thornley M, Wraith E, Barrera LA, Giugliani R, Schwartz IV, Frenking GS, Beck M, Kircher SG, Paschke E, Yamaguchi S, Ullrich K, Isogai K, Suzuki Y, Orii T, Kondo N, Creer M, Noguchi A (2004) Development and testing of new screening method for keratan sulfate in mucopolysaccharidosis IVA. Pediatr Res 55:592-597
19. Tomatsu S, Okamura K, Taketani T, Orii KO, Nishioka T, Gutierrez MA, Velez-Castrillon S, Fachel AA, Grubb JH, Cooper A, Thornley M, Wraith E, Barrera LA, Giugliani R, Schwartz IV, Frenking GS, Beck M, Kircher SG, Paschke E, Yamaguchi S, Ullrich KK, Isogai K, Suzuki Y, Orii T, Kondo N, Creer M, Noguchi A (2005) Keratan sulfate levels in mucopolysaccharidoses and mucolipidoses. J Inherit Metab Dis 28:187-202
20. Tomatsu S, Montaño AM, Ohashi A, Oikawa H, Oguma T, Dung VC, Nishioka T, Orii T, Sly WS (2008) Enzyme replacement therapy in a murine model of Morquio A syndrome. Hum Mol Genet 17:815-824
21. Tomatsu S, Montaño AM, Ohashi A, Oikawa H, Oguma T, Dung VC, Nishioka T, Orii T, SlyWS (2008) Enzyme replacement therapy in a murine model ofMorquio Asyndrome. HumMol Genet 17:815-824
22. Toyoda H, Demachi Y, Komoriya S, Furuya N, Toida T, Imanari T (1998) Characterization and determination of human urinary keratan sulfate. Chem Pharm Bull 46:97-101
23. Whitley CB, Ridnour MD, Draper KA, Dutton CM, Neglia JP (1989) Diagnostic test for mucopolysaccharidosis I. Direct method for quantifying excessive urinary glycosaminoglycan excretion. Clin Chem 35:374-379
24. Yamada H, Miyauchi S, Morita M, Yoshida Y, Yoshihara Y, Kikuchi T, Washimi O, Washimi Y, Terada N, Seki T, Fujikawa K (2000) Content and sulfation pattern of keratan sulfate in hip osteoarthritis using high performance liquid chromatography. J Rheumatol 27:1721-1724